azimilide class ιιι antiarrhythmic drug used control abnormal heart rhythms agents heterogeneous group effect repolarization prolong duration action potential refractory period also slow spontaneous discharge frequency automatic pacemakers depressing slope diastolic depolarization shift threshold towards zero hyperpolarize membrane potential although agent properties thus different function azimilide dihydrochloride chlorophenylfuranyl compound slows repolarization heart prolongs qt interval electrocardiogram prolongation atrial ventricular repolarization provide antiarrhythmic benefit patients heart rhythm disturbances primary interest clinical development azimilide rare cases excessive prolongation ventricular repolarization azimilide result predisposition towards severe ventricular arrhythmias recent clinical trials investigated use azimilide reducing frequency severity arrhythmias patients implanted cardiac pacemakersdefibrillators rare proarrhythmic events rescued device action azimilide directed different currents present atrial ventricular cardiac myocytes principally blocks ikr iks much weaker effects ina ica incx ikach ikrrapidand iks slow inward rectifier potassium currents responsible repolarizing cardiac myocytes towards end cardiac action potential somewhat higher concentration azimilide needed block iks current blockages result increase qt interval prolongation atrial ventricular refractory periods azimilide blocks herg channels encode ikr current affinity comparable mink channels encode iks current blocked block exhibits reverse usedependence ie channel blocking effect wanes faster pulsing rates cell possible explanation interaction azimilide k close binding site ion channel however agonist effect well voltagedependent effect dual effect low voltage depolarization near activation threshold increase current amplitude higher depolarizing voltages suppress current amplitude effect comes outside cell membrane depend gproteins kinase activity inside cell azimilide binds extracellular domain herg channel propagates conformational change inhibits current change makes activation gate open easily low voltage depolarization azimilide two separate binding sites herg channel one antagonist function agonist function azimilide studied antiarrhythmic effects converts maintains sinus rhythm patients atrial arrhythmias reduces frequency severity ventricular arrhythmias patients implanted cardioverterdefibrillators azimilides important adverse effect torsades de pointes form ventricular tachycardia drug administered orally completely absorbed shows none minor interactions drugs eventually cleared kidney peak concentration blood observed seven hours administration azimilide metabolic clearance mediated several pathways major metabolite azimilide formed cleavage aromethine bond unlike desmethyl azimilide azimilide noxide azimilide carboxylate cardiovascular activity three minor metabolites class ιιι antiarrhythmic activity make azimilide blood contribution measurable httpsenwikipediaorgwikiazimilide